Medicare Enrolled

Dr. Kem Yenal, MD

Family Medicine · Phila, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1741 FRANKFORD AVE, Phila, PA 19125
2154252424
In practice since 2005 (20 years)
NPI: 1215913868 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yenal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yenal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yenal

Dr. Kem Yenal is a family medicine specialist in Phila, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Yenal performed 13 Medicare services across 13 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yenal received a total of $26,419 from 50 pharmaceutical and/or device companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yenal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 13 Medicare services $26,419 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13
Medicare services
13
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
13 $60 $138
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$26,419
Total received (2018-2024)
Avg $3,774/year across 7 years
Top 1% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
730
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,483 (85.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,936 (14.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,740
2023
$847
2022
$2,304
2021
$2,519
2020
$969
2019
$10,147
2018
$6,892

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ModernaTX, Inc.
$1,711
AstraZeneca Pharmaceuticals LP
$317
Teva Pharmaceuticals USA, Inc.
$222
Alexion Pharmaceuticals, Inc.
$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$100
SANOFI-AVENTIS U.S. LLC
$99
Xeris Pharmaceuticals, Inc.
$95
Janssen Pharmaceuticals, Inc
$33
Indivior Inc.
$33
Alkermes, Inc.
$28
Top 3 companies account for 82.1% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI US SERVICES INC.
$3,936
Novo Nordisk Inc
$3,010
GlaxoSmithKline, LLC.
$1,973
AstraZeneca Pharmaceuticals LP
$1,959
ModernaTX, Inc.
$1,711
SANOFI-AVENTIS U.S. LLC
$1,494
Janssen Pharmaceuticals, Inc
$1,477
PFIZER INC.
$1,209
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,095
Lilly USA, LLC
$942
Astellas Pharma US Inc
$900
Amarin Pharma Inc.
$680
Novartis Pharmaceuticals Corporation
$534
Merck Sharp & Dohme Corporation
$527
Daiichi Sankyo Inc.
$366
ABBVIE INC.
$365
AbbVie Inc.
$349
Bayer HealthCare Pharmaceuticals Inc.
$344
AbbVie, Inc.
$273
Allergan Inc.
$257
Corcept Therapeutics
$244
Biohaven Pharmaceuticals, Inc.
$241
Teva Pharmaceuticals USA, Inc.
$236
Abbott Laboratories
$234
Amgen Inc.
$201
Gilead Sciences, Inc.
$168
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$161
Takeda Pharmaceuticals U.S.A., Inc.
$142
Circassia Pharmaceuticals Inc
$138
Xeris Pharmaceuticals, Inc.
$138
Biohaven Pharmaceutical Holding Company Ltd.
$136
ITI, Inc.
$126
E.R. Squibb & Sons, L.L.C.
$125
Alexion Pharmaceuticals, Inc.
$103
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$100
Sunovion Pharmaceuticals Inc.
$90
Alkermes, Inc.
$65
Otsuka America Pharmaceutical, Inc.
$53
Ironwood Pharmaceuticals, Inc
$38
Shire North American Group Inc
$36
Avanir Pharmaceuticals, Inc.
$34
Indivior Inc.
$33
Merck Sharp & Dohme LLC
$32
Regeneron Healthcare Solutions, Inc.
$31
Phadia US Inc.
$28
Esperion Therapeutics, Inc.
$27
Medtronic MiniMed, Inc.
$17
Nabriva Therapeutics, plc
$15
Kowa Pharmaceuticals America, Inc.
$14
UCB, Inc.
$13
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ANORO · ANORO ELLIPTA · ARISTADA · AUSTEDO · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BRILINTA · BYDUREON · Briviact · CAPLYTA · CHANTIX · COLOGUARD · CREON · Creon · DUZALLO · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FASENRA · FREESTYLE LIBRE 3 · FreeStyle Libre Pro · GARDASIL · GVOKE HYPOPEN · GVOKE PFS · INJECTAFER · INVEGA SUSTENNA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LATUDA · LEXISCAN · LINZESS · LOKELMA · LYBALVI · LYRICA · Livalo · MYRBETRIQ · Minimed 630G · Myrbetriq · NEXLIZET · NO PRODUCT DISCUSSED · NUCALA · NUEDEXTA · NURTEC ODT · OFEV · Otezla · Ozempic · PEDIARIX · PERSERIS · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TZIELD · Tresiba · Trintellix · Truvada · UBRELVY · ULTOMIRIS · UZEDY · Uloric · VESICARE · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xenleta · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in PA.

Looking for a family medicine specialist in Phila?
Compare family medicine physicians in the Phila area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,409
Per 100K population
152.2
County median income
$60,698
Nearest hospital
KENSINGTON HOSPITAL
1.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yenal is a mixed practice specialist, with low-engagement industry engagement in the top 1% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yenal experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Yenal performed 13 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yenal receive payments from pharmaceutical companies?
Yes. Dr. Yenal received a total of $26,419 from 50 companies across 730 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yenal's costs compare to other family medicine physicians in Phila?
Dr. Yenal's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yenal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →